Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 6/20 | 0.53 |
| ▸ | DOT1L | Q8TEK3 | 2/20 | 0.42 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.42 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.42 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.42 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | ROS1 | P08922 | 1/20 | 0.42 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | FLT3 | P36888 | 1/20 | 0.42 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.42 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.42 |
| ▸ | CLK2 | P49760 | 1/20 | 0.42 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.42 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.42 |
| ▸ | MELK | Q14680 | 1/20 | 0.42 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.42 |
| ▸ | HIPK4 | Q8NE63 | 1/20 | 0.42 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16402363 | 1.00 | ADK (0.53) | ADKDOT1LCDK5DCLK1DAPK3 | |
| SCHEMBL16402415 | 1.00 | ADK (0.53) | ADKDOT1LCDK5DCLK1DAPK3 | |
| SCHEMBL17806716 | 1.00 | ADK (0.53) | ADKDOT1LCDK5DCLK1DAPK3 | |
| SCHEMBL17805829 | 1.00 | ADK (0.53) | ADKDOT1LCDK5DCLK1DAPK3 | |
| SCHEMBL16402410 | 1.00 | ADK (0.53) | ADKDOT1LCDK5DCLK1DAPK3 | |
| SCHEMBL17806717 | 1.00 | ADK (0.53) | ADKDOT1LCDK5DCLK1DAPK3 | |
| SCHEMBL16402540 | 1.00 | ADK (0.53) | ADKDOT1LCDK5DCLK1DAPK3 | |
| SCHEMBL22446806 | 1.00 | ADK (0.53) | ADKDOT1LCDK5DCLK1DAPK3 | |
| SCHEMBL21412884 | 1.00 | ADK (0.53) | ADKDOT1LCDK5DCLK1DAPK3 | |
| SCHEMBL26388877 | 1.00 | ADK (0.53) | ADKDOT1LCDK5DCLK1DAPK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220248666-A1 | COMPOSITIONS AND METHODS FOR PRESERVING RED BLOOD CELLS AND PLATELETS | RYTHRX THERAPEUTICS, LLC | 2022-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220248666-A1 | COMPOSITIONS AND METHODS FOR PRESERVING RED BLOOD CELLS AND PLATELETS | RCN1, THPO, TYMP | ADK 977/4885DOT1L 2101/4885CDK5 1591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.